Medizinische Universität Graz - Research portal
Mayrhofer Katrin |
** = Publications listed in SCI/SSCI/Pubmed
2025
Abstract (Journal)
** Niedersuess-Beke, D; Pichler, R; Krauter, J; Luger, F; Vais, D; Taedcke, R; Aufderklamm, S; Stoiber, F; Shariat, SF; Schnabel, S; Gampenrieder, SP; Muehlmann, J; Spiegelberg, J; Bauernhofer, T; Banner, A; Weibrecht, S; Wiesinger, C; Miechowiecki, J; Heintel, D; Mayrhofer, K
Treatment, tolerability and outcomes of enfortumab vedotin plus pembrolizumab in advanced urothelial carcinoma: An analysis of the Austrian enfortumab registry.
J CLIN ONCOL. 2025; 43(5_SUPPL): 736
Doi: 10.1200/JCO.2025.43.5_suppl.736
Web of Science
FullText
FullText_MUG
2016
Full paper/article (Journal)
** Seles, M; Gutschi, T; Mayrhofer, K; Fischereder, K; Ehrlich, G; Gallé, G; Gutschi, S; Pachernegg, O; Pummer, K; Augustin, H
Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.
BJU Int. 2016; 117(4):592-597
Doi: 10.1111/bju.13108
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Review
** Augustin, H; Mayerhofer, K; Seles, M; Pummer, K
Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131
Doi: 10.1159/000371895
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Full paper/article (Journal)
** Augustin, H; Mayrhofer, K; Pummer, K; Mannweiler, S
Relationship between prostate cancer gene 3 (PCA3) and characteristics of tumor aggressiveness.
Prostate. 2013; 73(2):203-210
Doi: 10.1002/pros.22558
Web of Science
PubMed
FullText
FullText_MUG
2012
Abstract (Journal)
** Auprich, M; Chun, FKH; Mayrhofer, K; Haese, A; Mannweiler, S; Ward, JF; Gutschi, ST; Babaian, R; Pummer, K; Augustin, H
Is the preoperative urinary prostate cancer gene 3 (PCA3) score's associated with Gleason score dependent tumor volume and Gleason pattern specific tumor volume?
EUR UROL SUPPL. 2012; 11(1): E1004-U103.
[Poster]
Web of Science